Since its founding in Rostock, Germany, SensID has focused on advancing molecular diagnostics through highly characterized reference materials and quality controls.
In 2024, SensID became part of Microbiologics, expanding global capabilities in molecular diagnostics, oncology, and diagnostic quality solutions while continuing its commitment to scientific excellence and innovation.


